STAT6 Activation Exacerbates Ferroptosis in Airway Epithelium by Inhibiting PRKN‐Mediated Mitophagy in Pulmonary Fibrosis
Advanced Science · 2025
DOI: 10.1002/advs.202501718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Youjing Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key laboratory of Emergency Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing, 400014, China. Hauptthemen laut MEDLINE: Ferroptosis, Mitophagy, STAT6 Transcription Factor, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Research Program of Chongqing Municipal Education Commission, Chongqing Key Laboratory of Emergency Medicine.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) remains a clinically intractable condition with limited therapies. Ferroptosis has emerged as a critical driver of PF. The previous study demonstrates that increased secretion of tissue plasminogen activator from ferroptotic airway epithelial cells contributes to PF progression in a paracrine manner. Herein, the indispensable role of signal transducer and activator of transduction 6 (STAT6) is further elucidated in maintaining airway epithelial homeostasis during PF and uncovers a novel mechanism by which STAT6 regulates mitophagy to modulate ferroptosis. Specifically, mitophagy is induced during PF along with STAT6 activation, and deficiency of STAT6 significantly alleviates epithelial ferroptosis and PF. Mechanistically, STAT6 directly binds to the parkin RBR E3 ubiquitin protein ligase (PRKN) promoter region at the site (−990 to −976), inhibiting PRKN transcription and thereby impairing mitophagy. Consistently, lentivirus‐mediated PRKN interference in both wild‐type and STAT6 knockout mice aggravates ferroptosis and PF. Furthermore, virtual screening identifies rifabutin as a potential STAT6 inhibitor, that exhibits therapeutic effects against PF both in vivo and in vitro. Collectively, these findings reveal an unreported mechanism by which STAT6 promotes PF by inhibiting PRKN‐mediated mitophagy in the airway epithelium. Rifabutin is further identified and validated as a promising STAT6 inhibitor to alleviate PF, offering new insights into therapy development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Key laboratory of Emergency Medicine, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing, 400014, China.
- Department of Trauma Surgery, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing, 400014, China.
- School of Medicine, Soochow University, Suzhou, 215006, China.
ORCID-Profile: Shasha Tao
Förderung
- National Natural Science Foundation of China
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Chongqing Key Laboratory of Emergency Medicine
- Natural Science Foundation of Chongqing Science and Technology Bureau
- Senior Medical Talents Program of Chongqing for Young and Middle-aged
- Key Project of Chongqing Municipal Health Commission Medical Research Program
Zitieren
APA
Yang, Y., Huang, G., Zhang, T., Ling, Y., Jiang, J., Du, D., Ma, Y., & Tao, S. (2025). STAT6 Activation Exacerbates Ferroptosis in Airway Epithelium by Inhibiting PRKN‐Mediated Mitophagy in Pulmonary Fibrosis. Advanced Science. https://doi.org/10.1002/advs.202501718
Vancouver
Yang Y, Huang G, Zhang T, Ling Y, Jiang J, Du D, et al. STAT6 Activation Exacerbates Ferroptosis in Airway Epithelium by Inhibiting PRKN‐Mediated Mitophagy in Pulmonary Fibrosis. Advanced Science. 2025. doi:10.1002/advs.202501718
BibTeX
@article{Yang2025,
author = {Yang, Youjing and Huang, Guangbin and Zhang, Tao and Ling, Yi and Jiang, Junyu and Du, Dingyuan and Ma, Yu and Tao, Shasha},
title = {STAT6 Activation Exacerbates Ferroptosis in Airway Epithelium by Inhibiting PRKN‐Mediated Mitophagy in Pulmonary Fibrosis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501718}
}
EUVIMED